Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 3.870
+0.170 (4.59%)
Dec 5, 2025, 2:25 PM CET
Arctic Bioscience AS Revenue
Arctic Bioscience AS had revenue of 18.70M NOK in the half year ending June 30, 2025, a decrease of -2.02%. This brings the company's revenue in the last twelve months to 45.90M, up 43.97% year-over-year. In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M with 31.55% growth.
Revenue (ttm)
45.90M
Revenue Growth
+43.97%
P/S Ratio
2.26
Revenue / Employee
2.09M
Employees
22
Market Cap
103.95M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 662.18M |
| Nordhealth AS | 590.33M |
| Photocure ASA | 537.59M |
| ArcticZymes Technologies ASA | 109.99M |
| Omda AS | 476.29M |
| Vistin Pharma ASA | 455.25M |
| Gentian Diagnostics ASA | 172.52M |
| Nykode Therapeutics AS | 73.37M |